Farther Finance Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8K Sell
400
-154
-28% -$4.71K ﹤0.01% 4174
2026
Q1
$18K Sell
554
-365
-40% -$12.2K ﹤0.01% 3733
2025
Q4
$31.8K Buy
919
+580
+171% +$18.5K ﹤0.01% 3114
2025
Q3
$9.22K Buy
339
+251
+285% +$6.07K ﹤0.01% 3474
2025
Q2
$1.85K Buy
88
+28
+47% +$537 ﹤0.01% 3725
2025
Q1
$886 Buy
60
+35
+140% +$746 ﹤0.01% 3643
2024
Q4
$643 Hold
25
﹤0.01% 3384
2024
Q3
$792 Buy
25
+4
+19% +$152 ﹤0.01% 3308
2024
Q2
$754 Hold
21
﹤0.01% 3163
2024
Q1
$893 Hold
21
﹤0.01% 2817
2023
Q4
$747 Buy
21
+16
+320% +$478 ﹤0.01% 2841
2023
Q3
$135 Buy
+5
New +$127 ﹤0.01% 2523

Other funds holding IDYA

Farther Finance Advisors's IDYA Position: Q2 2026 in Review

Farther Finance Advisors reduced its IDEAYA Biosciences (IDYA) stake by 28% in Q2 2026, selling an estimated $4.71K and leaving 400 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4174.

Farther Finance Advisors first reported a position in IDYA in Q3 2023 and has held it in 12 quarters since. The position peaked at $31.8K in Q4 2025. 16 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Farther Finance Advisors held 400 shares of IDEAYA Biosciences worth $14.8K as of Q2 2026.
  • Farther Finance Advisors sold 154 IDEAYA Biosciences shares in Q2 2026, an estimated $4.71K.
  • IDEAYA Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4174 holding.
  • Farther Finance Advisors first reported a position in IDEAYA Biosciences in Q3 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's IDEAYA Biosciences position peaked at $31.8K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.